1. PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells
   Shuguang Zhang et al, 2015, Tumor Biol. CrossRef
2. Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity
   Fei-Ting Hsu et al, 2015, BioMed Research International CrossRef
3. Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma
   Mankgopo M. Kgatle et al, 2016, BioMed Research International CrossRef
4. Cyclophilin D-mediated apoptosis attributes to sorafenib-induced cytotoxicity in clear cell-renal cell carcinoma
   Wei Hu et al, 2015, European Journal of Pharmacology CrossRef
5. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells
   Jai-Jen Tsai et al, 2017 CrossRef
6. Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma
   Jennifer Eatrides et al, 2017, Cancer Control CrossRef
7. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma
   Jian-Jun Gao, 2015, WJG CrossRef
8. Expression and purification of an FGF9 fusion protein in E. coli, and the effects of the FGF9 subfamily on human hepatocellular carcinoma cell proliferation and migration
   Shen Wang et al, 2017, Appl Microbiol Biotechnol CrossRef
9. Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
   Kwei-Yan Liu et al, 2018, Cancers CrossRef
10. Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-κB inactivation in SK-Hep1 cells
    Yu-Chang Liu et al, 2017 CrossRef
11. IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.
    Kemin Cai et al, 2017, Oncol Lett CrossRef
12. Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro
    Wei-Lung Chen et al, 2017 CrossRef
13. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia
    Yang-ling Li et al, 2018, Biochemical and Biophysical Research Communications CrossRef
14. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice
    Mao-Chi Weng et al, 2018, Biosci. Rep. CrossRef
15. Benzyl isothiocyanate inhibits human brain glioblastoma multiforme GBM 8401 cell xenograft tumor in nude mice in vivo
    Yi-Shih Ma et al, 2018, Environmental Toxicology CrossRef
16. Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective
    Diamantis I. Tsilimigras et al, 2018, Surgical Oncology CrossRef
17. Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells
    Yu-Cheng Chou et al, 2018, Molecules CrossRef
18. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
    Timothy J. Stuhlmiller et al, 2017, J Am Heart Assoc CrossRef
19. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro
    Wei-Ting Chen et al, 2019, IJMS CrossRef
20. Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo
    Fei-Ting Hsu et al, 2015, Sci Rep CrossRef
21. Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study
    Kaku Goto et al, 2016, Sci Rep CrossRef
22. Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
    Xiaohua Li et al, 2019, Sci Rep CrossRef
23. Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications
    Carolin Czauderna et al, 2019, Cancers CrossRef
24. Epigenetic therapy as a novel approach in hepatocellular carcinoma
    Ioannis Anestopoulos et al, 2015, Pharmacology & Therapeutics CrossRef
25. Inhibition of the VEGF signalling pathway and glomerular disorders
    Mario Ollero et al, 2015, Nephrol. Dial. Transplant. CrossRef
26. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling
    Jian Ouyang et al, 2016, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
27. Apoptosis induction and ERK/NF‐κB inactivation are associated with magnolol‐inhibited tumor progression in hepatocellular carcinoma in vivo
    Jai‐Jen Tsai et al, 2019, Environmental Toxicology CrossRef
28. Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma In Vitro and In Vivo
    Jai-Jen Tsai et al, 2020, Am. J. Chin. Med. CrossRef
29. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF‐κB signalling participate in anti‐glioblastoma of imipramine
    Fei-Ting Hsu et al, 2020, J Cell Mol Med CrossRef
30. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells
    Hang Lu et al, 2016, Oncotarget CrossRef
31. Is the era of sorafenib over? A review of the literature
    Guanghan Fan et al, 2020, Ther Adv Med Oncol CrossRef
32. Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A
    John Chen et al, 2018, Oncol Lett CrossRef
33. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities.
    Nikolaos Garmpis et al, 2021, J Pers Med CrossRef
34. Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway
    Yuan Cai et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
35. Combinatorial antitumor effects of amino acids and epigenetic modulations in hepatocellular carcinoma cell lines
    Yasmine A. Hassan et al, 2021, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
36. The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo
    Chun‐Min Su et al, 2021, Environmental Toxicology CrossRef
37. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo
    Ching-Hsuan Wu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
38. m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma.
    Xin-Yu Li et al, 2022, Front Bioeng Biotechnol CrossRef
39. Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway
    Shuiying Tang et al, 2023, JHC CrossRef
40. Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
    Zhonghao Jiang et al, 2023, JHC CrossRef
41. Ameliorative Effect of Posidonia oceanica on High Glucose-Related Stress in Human Hepatoma HepG2 Cells
    Marzia Vasarri et al, 2023, IJMS CrossRef